IL31 and poikiloderma with neutropenia: However, the clinical relevance of the IL‐31 signalling pathway has been substantiated in studies with IL‐31 blocking‐targeting drugs, which significantly improved pruritus in patients with PN independent of ethnicity, age, gender or comorbidity.2, 25